Press release content from Accesswire. The AP news staff was not involved in its creation.
Evotec And Related Sciences Enter Integrated Drug Discovery and Development Partnership
February 9, 2021 GMT
PARTNERSHIP COMBINES RELATED SCIENCES’ COLLABORATIVE SCIENCE MODEL AND DATA-DRIVEN APPROACH TO IDENTIFYING BIOLOGICAL BREAKTHROUGHS WITH EVOTEC’S INTEGRATED PLATFORM TO DRIVE INNOVATIVE MULTIMODALITY DRUG DISCOVERY FROM TARGET TO CLINIC
EVOTEC WILL BENEFIT FROM SUCCESS THROUGH MILESTONES, ROYALTIES AND FOUNDING EQUITY STAKES IN ALL RELATED SCIENCES ASSETS DEVELOPED WITHIN THIS COLLABORATION
HAMBURG, GERMANY / ACCESSWIRE / February 9, 2021 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that the Company has entered into an integrated multi-target drug discovery agreement with biotech venture creation firm Related Sciences to generate multiple drug development candidates, biomarkers, and IND filings over a multi-year period.